The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials.
- 1 January 2004
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 27 (3) , 203-213
- https://doi.org/10.2165/00002018-200427030-00005
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Mefloquine-induced Paranoid Psychosis and Subsequent Major Depression in a 25-year-old StudentPharmacopsychiatry, 2002
- Cigarette Smoking and Panic: The Role of NeuroticismAmerican Journal of Psychiatry, 2002
- One-year prevalence of long-term functional psychosis in three different areas of UppsalaActa Psychiatrica Scandinavica, 1997
- The National Psychiatric Morbidity Surveys of Great Britain – initial findings from the Household SurveyPsychological Medicine, 1997
- Depression in the communityInternational Clinical Psychopharmacology, 1997
- Malaria Chemoprophylaxis in German Tourists: A Prospective Study on Compliance and Adverse ReactionsJournal of Travel Medicine, 1996
- Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East AfricaThe Lancet, 1993
- Further validation of information recorded on a general practitioner based computerized data resource in the united kingdomPharmacoepidemiology and Drug Safety, 1992
- Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.BMJ, 1991
- Are we entering an age of melancholy? Depressive illnesses in a prospective epidemiological study over 25 years: the Lundby Study, SwedenPsychological Medicine, 1982